Esperion Therapeutics
·Active·New
Entry
2026
Hold
New
Status
Active
Who owns Esperion Therapeutics?
Esperion Therapeutics is a private equity-backed company, currently owned by ARCHIMED since 2026.
Hand-verified · updated 2026-05-07
Open JSON · CC-BY
More from MED Platform II
Other portfolio companies in the same fund.
US
ItalyQuestions
Who owns Esperion Therapeutics?
Esperion Therapeutics is currently owned by ARCHIMED, through MED Platform II, since 2026.
When did ARCHIMED acquire Esperion Therapeutics?
ARCHIMED acquired Esperion Therapeutics in 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue